Tomàs Pinós Selected Research

Muscle Form Glycogen Phosphorylase (Myophosphorylase)

1/2018	Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
1/2018	Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
4/2016	Exercise and Preexercise Nutrition as Treatment for McArdle Disease.
2/2016	Genes and exercise intolerance: insights from McArdle disease.
7/2015	McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene.
12/2014	PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
7/2012	Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomàs Pinós Research Topics

Disease

19	Glycogen Storage Disease Type V (McArdle's Disease) 04/2022 - 07/2012
3	Glycogen Storage Disease (Glycogenosis) 05/2016 - 07/2012
2	Muscular Diseases (Myopathy) 04/2022 - 04/2013
2	Contracture 04/2022 - 12/2014
2	Ophthalmoplegia (External Ophthalmoplegia) 04/2013 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 11/2010 - 01/2008
1	Muscular Atrophy (Muscle Atrophy) 01/2022
1	Myoglobinuria 11/2020
1	Disease Progression 01/2019
1	Inflammation (Inflammations) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018
1	Fatigue 12/2014
1	Sarcopenia 12/2013
1	Proteinuria 04/2013
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2012
1	Communicable Diseases (Infectious Diseases) 11/2011
1	Hearing Loss (Hearing Impairment) 11/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2011
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2011
1	Neoplasms (Cancer) 10/2009
1	Carcinoma (Carcinomatosis) 01/2008

Drug/Important Bio-Agent (IBA)

12	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 04/2022 - 03/2015
10	GlycogenIBA 12/2021 - 05/2015
8	Protein Isoforms (Isoforms)IBA 04/2022 - 01/2008
7	Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA 01/2018 - 07/2012
6	EnzymesIBA 01/2020 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2010
2	Mitochondrial DNA (mtDNA)IBA 01/2018 - 11/2011
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	ProteomeIBA 04/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2020
1	antibiotic G 418IBA 01/2020
1	amlexanox (Aphthasol)FDA Link 01/2020
1	atalurenIBA 01/2020
1	2- imino- 5- ((5- (2- nitrophenyl)furan- 2- yl)methylene)thiazolidin- 4- oneIBA 01/2020
1	Transfer RNA (tRNA)IBA 01/2018
1	glucose-1-phosphateIBA 07/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2015
1	MyostatinIBA 12/2013
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 04/2013
1	Asn Transfer RNAIBA 04/2013
1	Nonsense Codon (Nonsense Mutation)IBA 07/2012
1	NucleotidesIBA 11/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2011
1	AminoglycosidesIBA 11/2011
1	12S ribosomal RNAIBA 11/2011
1	Cytochromes c (Cytochrome c)IBA 01/2011
1	Ala Transfer RNAIBA 01/2011
1	5' Untranslated Regions (5' UTR)IBA 11/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2009
1	Estrogen Receptor betaIBA 01/2008

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2014